16-55483320-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_004530.6(MMP2):c.380+185G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.765 in 152,150 control chromosomes in the GnomAD database, including 44,973 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.76 ( 44973 hom., cov: 33)
Consequence
MMP2
NM_004530.6 intron
NM_004530.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.716
Publications
26 publications found
Genes affected
MMP2 (HGNC:7166): (matrix metallopeptidase 2) This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
MMP2 Gene-Disease associations (from GenCC):
- multicentric osteolysis, nodulosis, and arthropathyInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- multicentric osteolysis-nodulosis-arthropathy spectrumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-55483320-G-A is Benign according to our data. Variant chr16-55483320-G-A is described in ClinVar as Benign. ClinVar VariationId is 1226528.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.819 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MMP2 | NM_004530.6 | c.380+185G>A | intron_variant | Intron 2 of 12 | ENST00000219070.9 | NP_004521.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.765 AC: 116316AN: 152032Hom.: 44947 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
116316
AN:
152032
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.765 AC: 116390AN: 152150Hom.: 44973 Cov.: 33 AF XY: 0.766 AC XY: 57003AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
116390
AN:
152150
Hom.:
Cov.:
33
AF XY:
AC XY:
57003
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
26894
AN:
41498
American (AMR)
AF:
AC:
11845
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2714
AN:
3472
East Asian (EAS)
AF:
AC:
3537
AN:
5154
South Asian (SAS)
AF:
AC:
3959
AN:
4824
European-Finnish (FIN)
AF:
AC:
8766
AN:
10584
Middle Eastern (MID)
AF:
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
AC:
56107
AN:
68012
Other (OTH)
AF:
AC:
1574
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1359
2718
4078
5437
6796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
862
1724
2586
3448
4310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2604
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.